DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on January 7, 2005; DOI: 10.1124/dmd.104.001214


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.001214v1
33/4/530    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reilly, C. A.
Right arrow Articles by Yost, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reilly, C. A.
Right arrow Articles by Yost, G. S.


Received for publication June 30, 2004.
Revised January 4, 2005.
Accepted for publication January 5, 2005.

Structural and Enzymatic Parameters that Determine Alkyl Dehydrogenation/Hydroxylation of Capsaicinoids by P450 Enzymes

Christopher A. Reilly 1* Garold S. Yost 1

1 University of Utah

* Address correspondence to: E-mail: chris.reilly{at}pharm.utah.edu

Abstract

Previous studies on the metabolism of capsaicinoids, natural products isolated from chili peppers, demonstrated the production of unique macrocyclic, alkyl dehydrogenated, {omega}-, and {omega}-1-hydroxylated products. This study investigated the structural and enzymatic parameters that direct selective alkyl dehydrogenation and hydroxylation of capsaicinoids, using a variety of structurally related capsaicinoid analogues and cytochrome P450 enzymes. CYP2C9 preferentially catalyzed alkyl dehydrogenation while CYP2E1 and 3A4 catalyzed {omega}- and {omega}-1 hydroxylation, respectively. Analysis of incubations containing various P450s and structural variants of capsaicin by LC/MS/MS demonstrated similarities in the rate of capsaicinoid metabolism, but marked differences in the formation of specific metabolites. Production of macrocyclic and {omega}-1-hydroxylated metabolites from the various capsaicinoids was dependent on the structure of the alkyl terminus and P450 enzyme. A tertiary carbon at the {omega}-1 position, coupled to an adjacent unsaturated bond at the {omega}-2,3 position, enhanced the formation of the macrocyclic and dehydrogenated metabolites, and were requisite structural features for {omega}-1-hydroxylated product formation. Conversely, substrates lacking these structural features were efficiently oxidized to the {omega}-hydroxylated metabolite. These data were consistent with our working hypothesis that the metabolism of the alkyl portion of capsaicinoids was governed, in part, by the stability, and propensity to form an intermediate radical, and an "end-on" interaction with the iron-oxo active site of most P450 enzymes. These results provided valuable insights into the mechanisms by which P450s metabolize capsaicinoids and highlight critical chemical features that may also govern the metabolism of structurally related compounds including fatty acids, monoterpenes, and isoprenoids.


Key words: analytical pharmacology/toxicology, cell injury, CYP2C, CYP2E, CYP3A, cytochrome P450, human CYP enzymes, mass spectrometry, respiratory toxicants


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Sun, W. J. Ehlhardt, P. Kulanthaivel, D. L. Lanza, C. A. Reilly, and G. S. Yost
Dehydrogenation of Indoline by Cytochrome P450 Enzymes: A Novel "Aromatase" Process
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 843 - 851.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.